Format

Send to

Choose Destination
Future Med Chem. 2009 Jul;1(4):587-92. doi: 10.4155/fmc.09.58.

Opinion: the case for advertising pharmaceuticals direct to consumers.

Author information

1
Westminster Business School, University of Westminster, 35 Marylebone Road, London NW15LS, UK. autonf@wmin.ac.uk

Abstract

Direct-to-consumer advertising (DCTA) of prescription-only medicines is currently only permitted in the USA and New Zealand. While proponents of DCTA argue that it allows patients to make more informed choices about available treatment options, opponents claim that marketing inevitably presents a biased viewpoint of pharmaceutical products. Frank Auton, senior lecturer in marketing and business strategy at the University of Westminster, UK, presents his case in favor of advertising pharmaceuticals directly to patients.

PMID:
21426028
DOI:
10.4155/fmc.09.58
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center